Literature DB >> 11455608

alpha-helix formation: discontinuous molecular dynamics on an intermediate-resolution protein model.

A Voegler Smith1, C K Hall.   

Abstract

An intermediate-resolution model of small, homogeneous peptides is introduced, and discontinuous molecular dynamics simulation is applied to study secondary structure formation. Physically, each model residue consists of a detailed three-bead backbone and a simplified single-bead side-chain. Excluded volume and hydrogen bond interactions are constructed with discontinuous (i.e., hard-sphere and square-well) potentials. Simulation results show that the backbone motion of the model is limited to realistic regions of Phi-Psi conformational space. Model polyalanine chains undergo a locally cooperative transition to form alpha-helices that are stabilized by backbone hydrogen bonding, while model polyglycine chains tend to adopt nonhelical structures. When side-chain size is increased beyond a critical diameter, steric interactions prevent formation of long alpha-helices. These trends in helicity as a function of residue type have been well documented by experimental, theoretical, and simulation studies and demonstrate the ability of the intermediate-resolution model developed in this work to accurately mimic realistic peptide behavior. The efficient algorithm used permits observation of the complete helix-coil transition within 15 min on a single-processor workstation, suggesting that simulations of very long times are possible with this model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11455608     DOI: 10.1002/prot.1100

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  50 in total

1.  Revisiting the Ramachandran plot: hard-sphere repulsion, electrostatics, and H-bonding in the alpha-helix.

Authors:  Bosco K Ho; Annick Thomas; Robert Brasseur
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

2.  Molecular dynamics simulation of amyloid beta dimer formation.

Authors:  B Urbanc; L Cruz; F Ding; D Sammond; S Khare; S V Buldyrev; H E Stanley; N V Dokholyan
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

3.  Phase diagrams describing fibrillization by polyalanine peptides.

Authors:  Hung D Nguyen; Carol K Hall
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

4.  Spontaneous formation of twisted Aβ(16-22) fibrils in large-scale molecular-dynamics simulations.

Authors:  Mookyung Cheon; Iksoo Chang; Carol K Hall
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

5.  In silico study of amyloid beta-protein folding and oligomerization.

Authors:  B Urbanc; L Cruz; S Yun; S V Buldyrev; G Bitan; D B Teplow; H E Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

6.  Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides.

Authors:  Hung D Nguyen; Carol K Hall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

7.  Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model.

Authors:  Feng Ding; Sergey V Buldyrev; Nikolay V Dokholyan
Journal:  Biophys J       Date:  2004-11-08       Impact factor: 4.033

8.  Monte Carlo studies of folding, dynamics, and stability in alpha-helices.

Authors:  Dalit Shental-Bechor; Safak Kirca; Nir Ben-Tal; Turkan Haliloglu
Journal:  Biophys J       Date:  2005-01-14       Impact factor: 4.033

9.  N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.

Authors:  Yiming Wang; Qing Shao; Carol K Hall
Journal:  J Biol Chem       Date:  2016-08-30       Impact factor: 5.157

10.  Simulations and Experiments Delineate Amyloid Fibrilization by Peptides Derived from Glaucoma-Associated Myocilin.

Authors:  Yiming Wang; Yuan Gao; Shannon E Hill; Dustin J E Huard; Moya O Tomlin; Raquel L Lieberman; Anant K Paravastu; Carol K Hall
Journal:  J Phys Chem B       Date:  2018-05-21       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.